HIV=AIDS: Fact or Fraud? A Stephen Allen film.
A shocking documentary that exposes
HIV/AIDS as a deceptive and deadly scam
This is a systematic dissection of the HIV/AID$ machine and how they hijacked a program designed to fight a worldwide plight of human suffering and drove it down the road to hell. Yet this program offers hope, inspired by the courage and articulate arguments of a group of growing voices internationally challenging the HIV=AIDS=DEATH hysteria. A MUST SEE for anyone interested in truly understanding the facts about HIV/AID$.
http://www.hiv-aids-factorfraud.com/producer.htmThe Other Side of AIDS
Winner of the Special Jury Prize at the AFI Los Angeles International Film Festival, THE OTHER SIDE OF AIDS gives voice to a growing global movement of doctors, scientists, journalists and HIV positives who are challenging the idea that HIV is the cause of AIDS. Scovill's third feature film, THE OTHER SIDE OF AIDS takes an unflinching look beyond the hype and the headlines and into an issue the mainstream media doesn't dare touch: the failure of the multi billion-dollar war on AIDS.
http://www.robinscovill.com/othersideofaids.htmlAIDS Inc. A Gary Null Film
AIDS, Inc. is a film about the multi-billion dollar AIDS industry, and how it profits from continuing fears and misconceptions about the disease. While AIDS grabs the headlines and raises billions of dollars with celebrity endorsements and billionaire endowments, we are no closer to finding a cure than when the scourge first appeared 30 years ago. Could it be that after so many years of research, and so much money being spent, that the entire orthodox medical establishment has been wrong about AIDS, or even worse, has sought to profit on a system that it knew was flawed from the beginning?
Deconstructing The Myth Of AIDS Gary Null
The Aids Myth and Deception, The Real Disease is Malnutrition and Drugs
Are New Drug Treatments Responsible for Declines in AIDS?
Government officials, AIDS organizations and the media unanimously agree that the recent decline in AIDS cases and deaths is an unprecedented occurrence due to a new combination of drugs that include protease inhibitors, chemicals said to block the replication of HIV. However, a careful look behind the headlines reveals that there is no medical evidence to support these popular claims about the protease inhibitor "combo cocktails.
"
The declines in AIDS deaths attributed to combination therapies actually began several years before protease inhibitor drugs became available for general use. (72) Since the first protease inhibitor received Food and Drug Administration (FDA) approval in December of 1995, a more likely explanation for decreased deaths would be the change in the official AIDS definition adopted in 1993 which allows HIV positives with no symptoms or illness to be diagnosed with AIDS. Since 1993, more than half of all newly diagnosed AIDS cases are counted among people who are not sick.
(73)
CDC data also show that decreases in AIDS cases commonly ascribed to "AIDS cocktails" preceded the introduction of the new drug treatments by three full years. According to the CDC's HIV/AIDS Surveillance Report, AIDS diagnoses peaked in the third quarter of 1991, increased once in the first quarter of 1993 as a result of the 1993 expanded AIDS definition, and have dropped each year since.
(75)
News stories of AIDS patients who rise from their death beds to run marathons after taking the drug cocktails, are just that -- stories. In science, such unverified accounts are dismissed as anecdotal, a term that comes from the Greek word anekdotos, meaning unpublished.
None of the anecdotal tales of recoveries attributed to new drug combinations have been substantiated by controlled studies published in peer-reviewed medical journals, a fact acknowledged in the fine print of pharmaceutical advertisements:
"At this time there is no evidence that Ziagen will help you live longer or have fewer of the medical problems associated with HIV or AIDS.
"
"It is not yet known whether Crixivan will extend your life or reduce your chances of getting other illnesses associated with HIV.
"
"At present, there are no results from controlled clinical trials evaluating the effects of Viramune [on] the incidence of opportunistic infections or survival.
"
"There have been no clinical trials conducted with Combivir.